News >
02/10/2001 - 22:00

Vaccine approval

By Staff Reporters
02/10/2001 - 22:00
Share to

Bookmark

Save articles for future reference.
Subscribe to BN Log In

AUSTRALIAN Cancer Technology Limited is set to begin human trials of its p53 cancer vaccine, Pentrix, at St Vincent’s Hospital, Sydney, after receiving all required approvals.

X

To read our articles you will need to either login or subscribe.